GF
BLACU

Gabelli Funds’s Bellevue Life Sciences Acquisition Corp. Unit BLACU Stock Holding History

Gabelli Funds’s Portfolio BLACU Stock Details BLACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-29,200
Closed -$301K – 1161
2023
Q1 		$301K Buy
+29,200
New +$299K ﹤0.01% 981

Other funds holding BLACU

PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
TAM
Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return

Gabelli Funds's BLACU Position: Q2 2023 in Review

Gabelli Funds sold out of Bellevue Life Sciences Acquisition Corp. Unit (BLACU) in Q2 2023, closing a stake of 29,200 shares — an estimated $301K sold.

Gabelli Funds first reported a position in BLACU in Q1 2023 and held it in 1 quarter. The position peaked at $301K in Q1 2023. 13 funds tracked by Wall St. Rank hold BLACU as of Q2 2023.

  • Gabelli Funds reported no remaining Bellevue Life Sciences Acquisition Corp. Unit position as of Q2 2023 after selling out during the quarter.
  • Gabelli Funds sold 29,200 Bellevue Life Sciences Acquisition Corp. Unit shares in Q2 2023, an estimated $301K.
  • Gabelli Funds first reported a position in Bellevue Life Sciences Acquisition Corp. Unit in Q1 2023 and held it in 1 quarter.
  • Gabelli Funds's Bellevue Life Sciences Acquisition Corp. Unit position peaked at $301K in Q1 2023.
  • 13 funds tracked by Wall St. Rank held Bellevue Life Sciences Acquisition Corp. Unit as of Q2 2023.

Based on Gabelli Funds's 13F filing for Q2 2023, filed 10 Aug 2023.